Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. D-propoxyphene Napsylate
2. Dextropropoxyphene Napsylate
1. 17140-78-2
2. Propoxyphene Napsylate Anhydrous
3. 5o7iw35n3c
4. Darvon N
5. [(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] Propanoate;naphthalene-2-sulfonic Acid
6. Propoxyphene-n
7. (+)- Propoxyphene Napsylate
8. Propoxyphene 2-naphthalenesulfonate
9. Einecs 241-205-7
10. Unii-5o7iw35n3c
11. 2-butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, Propionate, 2-naphthalenesulfonate
12. Propoxyphene Napsylate ,(s)
13. 2-naphthalenesulfonic Acid, Compd. With (s-(r*,s*))-3-(dimethylamino)-2-methyl-1-phenyl-1-(phenylmethyl)p- Ropyl Propanoate (1:1)
14. Schembl9297768
15. Dtxsid80937986
16. Propoxyphene Napsylate, Anhydrous
17. 2-naphthalenesulfonic Acid, Compd. With (+)-alpha-(2-dimethylamino)-1-methylethyl-alpha-phenylphenethyl Propionate (1:1)
18. Benzeneethanol, Alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, Propanoate (ester), (1s,2r)-, 2-naphthalenesulfonate (salt)
19. Benzeneethanol, Alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, Propanoate (ester), (s-(r*,s*))-, 2-naphthalenesulfonate (salt)
20. Naphthalene-2-sulphonic Acid, Compound With (s-(r*,s*))-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl Propionate (1:1)
21. Q27262632
22. (2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl Propionate Naphthalene-2-sulfonate
Molecular Weight | 547.7 g/mol |
---|---|
Molecular Formula | C32H37NO5S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | 547.23924445 g/mol |
Monoisotopic Mass | 547.23924445 g/mol |
Topological Polar Surface Area | 92.3 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 688 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
55
PharmaCompass offers a list of Propoxyphene Napsylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Propoxyphene Napsylate manufacturer or Propoxyphene Napsylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Propoxyphene Napsylate manufacturer or Propoxyphene Napsylate supplier.
PharmaCompass also assists you with knowing the Propoxyphene Napsylate API Price utilized in the formulation of products. Propoxyphene Napsylate API Price is not always fixed or binding as the Propoxyphene Napsylate Price is obtained through a variety of data sources. The Propoxyphene Napsylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DARVOCET-N 50-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DARVOCET-N 50-1, including repackagers and relabelers. The FDA regulates DARVOCET-N 50-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DARVOCET-N 50-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A DARVOCET-N 50-1 supplier is an individual or a company that provides DARVOCET-N 50-1 active pharmaceutical ingredient (API) or DARVOCET-N 50-1 finished formulations upon request. The DARVOCET-N 50-1 suppliers may include DARVOCET-N 50-1 API manufacturers, exporters, distributors and traders.
click here to find a list of DARVOCET-N 50-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DARVOCET-N 50-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of DARVOCET-N 50-1 active pharmaceutical ingredient (API) in detail. Different forms of DARVOCET-N 50-1 DMFs exist exist since differing nations have different regulations, such as DARVOCET-N 50-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DARVOCET-N 50-1 DMF submitted to regulatory agencies in the US is known as a USDMF. DARVOCET-N 50-1 USDMF includes data on DARVOCET-N 50-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DARVOCET-N 50-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DARVOCET-N 50-1 suppliers with USDMF on PharmaCompass.
DARVOCET-N 50-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DARVOCET-N 50-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DARVOCET-N 50-1 GMP manufacturer or DARVOCET-N 50-1 GMP API supplier for your needs.
A DARVOCET-N 50-1 CoA (Certificate of Analysis) is a formal document that attests to DARVOCET-N 50-1's compliance with DARVOCET-N 50-1 specifications and serves as a tool for batch-level quality control.
DARVOCET-N 50-1 CoA mostly includes findings from lab analyses of a specific batch. For each DARVOCET-N 50-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DARVOCET-N 50-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (DARVOCET-N 50-1 EP), DARVOCET-N 50-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DARVOCET-N 50-1 USP).